Compare VIRC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIRC | PYPD |
|---|---|---|
| Founded | 1950 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.1M | 85.1M |
| IPO Year | 1995 | 2014 |
| Metric | VIRC | PYPD |
|---|---|---|
| Price | $6.27 | $4.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.30 | ★ $12.25 |
| AVG Volume (30 Days) | 120.4K | ★ 155.6K |
| Earning Date | 04-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $199,652,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.77 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.16 | $3.06 |
| 52 Week High | $9.07 | $5.24 |
| Indicator | VIRC | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 56.87 |
| Support Level | $5.99 | $4.18 |
| Resistance Level | $6.50 | $5.09 |
| Average True Range (ATR) | 0.34 | 0.27 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 38.82 | 70.27 |
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.